delirium/neoplasms

Linkul este salvat în clipboard

Alegeți tipul de sortare

Pagină 1 din 830 rezultate

Delirium frequency among advanced cancer patients presenting to an emergency department: A prospective, randomized, observational study.

Numai utilizatorii înregistrați pot traduce articole

The frequency of delirium among patients with cancer presenting to the emergency department (ED) is unknown. The purpose of this study was to determine delirium frequency and recognition by ED physicians among patients with advanced cancer presenting to the ED of The University of Texas MD Anderson

Communication Capacity Scale and Agitation Distress Scale to measure the severity of delirium in terminally ill cancer patients: a validation study.

Numai utilizatorii înregistrați pot traduce articole

Although valid measurement of the severity of terminal delirium is of great importance in palliative care settings, existing instruments have considerable limitations. In order to quantify patients' communication capacity and agitated behaviour, two new operational observer-rating scales, the

Association of pre-operative brain pathology with post-operative delirium in a cohort of non-small cell lung cancer patients undergoing surgical resection.

Numai utilizatorii înregistrați pot traduce articole

OBJECTIVE Post-operative delirium is associated with pre-operative cognitive difficulties and diminished functional independence, both of which suggest that brain pathology may be present in affected individuals prior to surgery. Currently, there are few studies that have examined imaging correlates

Subcutaneous olanzapine for hyperactive or mixed delirium in patients with advanced cancer: a preliminary study.

Numai utilizatorii înregistrați pot traduce articole

BACKGROUND Oral olanzapine is effective in controlling agitation in patients with delirium, but often, parenteral administration is necessary. Intramuscular (IM) olanzapine is approved for managing agitation in schizophrenia, but this route is inappropriate for terminally ill patients. OBJECTIVE The

Management of altered mental status and delirium in cancer patients.

Numai utilizatorii înregistrați pot traduce articole

Delirium is a syndrome characterized by acute onset of changes in awareness and cognition, which fluctuate in severity during the episode. Altered mental status (AMS) and delirium have a high incidence rate among patients with cancer and this increases dramatically towards the end of life. Delirium

Delirium in advanced cancer patients.

Numai utilizatorii înregistrați pot traduce articole

Delirium in advanced cancer is often poorly identified and inappropriately managed. It is one of the most common causes for admission to clinical institutions and is the most frequently cited psychiatric disorder in terminal cancer. Diagnosis of delirium is defined as a disturbance of consciousness

The minimal clinically important difference of the Richmond Agitation-Sedation Scale in patients with cancer with agitated delirium.

Numai utilizatorii înregistrați pot traduce articole

BACKGROUND The Richmond Agitation-Sedation Scale (RASS) is commonly used to assess psychomotor activity; however, to the authors' knowledge, its minimal clinically important difference (MCID) has not been determined to date. The objective of the current study was to identify the MCID for RASS using

Are common delirium assessment tools appropriate for evaluating delirium at the end of life in cancer patients?

Numai utilizatorii înregistrați pot traduce articole

Objectives: The objectives of this study are to investigate how many advanced cancer patients became unconscious or non-communicative after pharmacological treatment for delirium, and to explore whether existing delirium assessment tools

Neuroleptic dose in the management of delirium in patients with advanced cancer.

Numai utilizatorii înregistrați pot traduce articole

Neuroleptics are commonly used in the management of delirium. Limited information is available regarding the dosage requirements and efficacy of neuroleptics in the palliative care setting. We determined the type and dose of neuroleptic use by delirium subtype. The medical records of 99 inpatients

Neuroleptics in the management of delirium in patients with advanced cancer.

Numai utilizatorii înregistrați pot traduce articole

Delirium is the most common and distressing neuropsychiatric syndrome in cancer patients. Few evidence-based treatment options are available due to the paucity of high quality of studies. In this review, we shall examine the literature on the use of neuroleptics to treat delirium in patients with

Effect of Lorazepam With Haloperidol vs Haloperidol Alone on Agitated Delirium in Patients With Advanced Cancer Receiving Palliative Care: A Randomized Clinical Trial.

Numai utilizatorii înregistrați pot traduce articole

The use of benzodiazepines to control agitation in delirium in the last days of life is controversial. To compare the effect of lorazepam vs placebo as an adjuvant to haloperidol for persistent agitation in patients with delirium in the setting of advanced cancer. Single-center, double-blind,

Delirium: assessment and treatment of patients with cancer. PART 2.

Numai utilizatorii înregistrați pot traduce articole

Delirium at the end of life may present significant ethical dilemmas in clinical practice: whether to simply treat it in order to maximise symptom relief, with the resulting side effect being palliative sedation, or to attempt to reverse delirium and risk prolonging suffering. Determining whether

Wernicke encephalopathy without delirium that appeared as agitation in a patient with lung cancer.

Numai utilizatorii înregistrați pot traduce articole

OBJECTIVE Wernicke encephalopathy (WE) is a neuropsychiatric disorder caused by thiamine deficiency, and is sometimes overlooked because of the diversity of clinical symptoms. METHODS From a series of WE patients with cancer, we report a lung cancer patient who developed WE, the main symptom of

Incidence and risk factors of subsyndromal delirium after curative resection of gastric cancer.

Numai utilizatorii înregistrați pot traduce articole

BACKGROUND Subsyndromal delirium, a condition in which patients exhibit some, but not all, of the symptoms of delirium, can negatively affect the outcomes of patients with cancer. However, the incidence of subsyndromal delirium in patients with gastric cancer is unknown. Here, we investigated the

Common psychiatric disorders in cancer patients. II. Anxiety and acute confusional states.

Numai utilizatorii înregistrați pot traduce articole

Anxiety is a very prominent symptom of cancer patients and appears most frequently in connection with adjustment disorders. However, it can also be part of a normal adaptation to the disease, related to an anxiety disorder, or can be caused by variety of other reasons, including underlying somatic

Anterior
1
2
3
4
5
6
...
55
56
Următor →

Alăturați-vă paginii
noastre de facebook

Herbal & Natural Medicine

Cea mai completă bază de date cu plante medicinale susținută de știință

Funcționează în 55 de limbi
Cure pe bază de plante susținute de știință
Recunoașterea ierburilor după imagine
Harta GPS interactivă - etichetați ierburile în locație (în curând)
Citiți publicațiile științifice legate de căutarea dvs.
Căutați plante medicinale după efectele lor
Organizați-vă interesele și rămâneți la curent cu noutățile de cercetare, studiile clinice și brevetele

Tastați un simptom sau o boală și citiți despre plante care ar putea ajuta, tastați o plantă și vedeți boli și simptome împotriva cărora este folosit.
* Toate informațiile se bazează pe cercetări științifice publicate